Boundless Bio, Inc. · NASDAQ:BOLD
Tang Kevin bought 21,640 Boundless Bio, Inc. shares (Form 4)
Traded Oct 22 to Oct 26, 2026 · Filed Oct 26, 2026
From Oct 22 to Oct 26, 2026, Tang Kevin (10% owner) bought 21,640 Boundless Bio, Inc. shares at an average US$2.39 for US$51,619, leaving 3,011,749 shares. Filed Oct 26, 2026 (Form 4).
- Bought
- 21,640 shares
- Price
- US$2.39 average (US$2.38 to US$2.40)
- Value
- US$51,619
- Holding after
- 3,011,749 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Buy | 5,800 | US$2.40 | 2,995,909 | Indirect |
| Oct 23, 2026 | Common Stock | Buy | 6,234 | US$2.38 | 3,002,143 | Indirect |
| Oct 26, 2026 | Common Stock | Buy | 9,606 | US$2.38 | 3,011,749 | Indirect |
Source
Download original · View original at SEC
Related
- Boundless Bio, Inc.
- Tang Kevin
- Boundless Bio, Inc. shareholders
- Form 4 · Tang Kevin · Oct 29, 2026
- Form 4 · Tang Kevin · Oct 20, 2026
- Form 4 · Tang Kevin · Jul 21, 2026
- Form 4 · Tang Kevin · Jul 16, 2026
- Form 4 · Tang Kevin · Jul 13, 2026
- Schedule 13G/A · Tang Capital Management LLC · Nov 16, 2026
- Form 4 · Tang Capital Management LLC · Aug 28, 2026
- Schedule 13G · Zachary Hornby · Aug 27, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026